SCHEMBL31747492

SCHEMBL31747492

C#CCCCc1ccc(C(=O)OC)cn1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ CYP4A11 Q02928 2/20 0.40
▸ MAOB P27338 4/20 0.40
▸ MAOA P21397 2/20 0.40
▸ MAPT P10636 3/20 0.40
▸ CYP4F2 P78329 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ RAB9A P51151 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALOX15 P16050 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31747479 0.96 MAPK1 (0.48) MAPK1KDM4EL3MBTL1CYP4A11MAOB
SCHEMBL22120004 0.85 MAPK1 (0.57) MAPK1KDM4EL3MBTL1CYP4A11MAPT
SCHEMBL20503310 0.82 MAPK1 (0.54) MAPK1KDM4EL3MBTL1CYP4A11MAPT
SCHEMBL31747413 0.82 P4HA1 (0.44) L3MBTL1MAPTALDH1A1
SCHEMBL13606287 0.81 CYP4A11 (0.60) MAPK1KDM4EL3MBTL1CYP4A11MAPT
SCHEMBL845815 0.81 MAPK1 (0.53) MAPK1KDM4EL3MBTL1CYP4A11MAPT
SCHEMBL31747404 0.81 CYP4A11 (0.60) MAPK1KDM4EL3MBTL1CYP4A11MAPT
SCHEMBL31747260 0.81 NNMT (0.45) KDM4EL3MBTL1
SCHEMBL31752289 0.81 MAPK1 (0.49) MAPK1KDM4EL3MBTL1MAOBMAOA
SCHEMBL31747416 0.80 CYP4A11 (0.59) MAPK1KDM4EL3MBTL1CYP4A11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262297-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2025-12-26 — — WO disclosed
EP-4667467-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2025-12-24 — — EP disclosed
Send feedback